Novo Holdings Akouos, Inc. Transaction History

Novo Holdings

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$7.65 - $11.38 $2.68 Million - $3.98 Million	350,045 Added 49.17%	1,061,990 $9.03 Million
Q3 2021 Nov 15, 2021	BUY	$9.93 - $13.59 $2.51 Million - $3.43 Million	252,655 Added 55.01%	711,945 $8.27 Million
Q4 2020 Feb 16, 2021	BUY	$17.03 - $22.45 $11,648 - $15,355	684 Added 0.15%	459,290 $9.11 Million
Q3 2020 Nov 16, 2020	SELL	$19.3 - $26.92 $177,174 - $247,125	-9,180 Reduced 1.96%	458,606 $10.5 Million
Q2 2020 Aug 14, 2020	BUY	$22.0 - $22.5 $10.3 Million - $10.5 Million	467,786 New	467,786 $10.5 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.